In recent years, Merlin's lab and others have explored how to
deliver conventional drugs via nanotechnology.
Not exact matches
Microdosing was used to treat one group of patients, while a
conventional eye dropper was used to
deliver the
drug to another group.
Researchers at New York Eye and Ear Infirmary of Mount Sinai showed that a microdose delivery system achieved a treatment effect comparable to a
conventional eyedropper, while
delivering less than four times the amount of
drug.
Unlike
conventional drugs, BNPs can be designed to
deliver therapeutic agents specifically to the site of inflammation.